VANCOUVER & DALLAS, April 10, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG) (“Alpha Cognition”, or the “Company”), a biopharmaceutical company committed to developing novel therapies for debilitating neurodegenerative disorders, today announced the appointment of Robert Wills, […]
Interview with Michael Swistun, President & CEO […]
Interview with Christopher Schaber, PhD CEO and President […]
Interview with Rory Ritchie, VP of Exploration […]
Broader protection induced by combination of COVID adenovirus vaccine plus CiVax™ compared to 2-shot mRNA vaccination series PRINCETON, N.J., March 25, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]
Conference Call Scheduled for March 31, 2025 4:30pm ET VANCOUVER, British Columbia & DALLAS, March 19, 2025–(BUSINESS WIRE)–Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that […]
Vancouver, British Columbia–(Newsfile Corp. – March 13, 2025) – Kobrea Exploration Corp. (CSE: KBX) (FSE: F3I) (OTCQB: KBXFF) (“Kobrea” or the “Company“) announces that it has commissioned a heli-borne magnetic and radiometric survey with New-Sense […]
Two Presentations Highlight Data Demonstrating Hypericin Photodynamic Therapy Potential with a Preliminary Comparison to Current Therapy PRINCETON, N.J., March 6, 2025 /PRNewswire/ — Soligenix, Inc. (Nasdaq: SNGX) (Soligenix or the Company), a late-stage biopharmaceutical company focused on […]
Vancouver, British Columbia–(Newsfile Corp. – February 18, 2025) – Kobrea Exploration Corp. (CSE: KBX) (FSE: F3I) (OTCQB: KBXFF) (“Kobrea” or the “Company“) announces that it has completed the next payment to the optionors under its […]
Copyright © 2019 The Wall Street Analyst, LLC. All rights reserved. Website by MyWebsiteSpot.com